/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Dr. González (PhD in Biochemistry 2003, University of Navarra, Spain) is the Director of the Program of Cardiovascular Disease (CIMA-Universidad de Navarra) and a group leader at the Spanish Cardiovascular Research Network (CIBERCV). She was granted the Norman R. Alpert Award in 2005 (ESC-AHA joint award). She was appointed as a Fellow of the Spanish Royal Academy of Science in 2023. She is also a member of the HFA Board since 2020 (Basic Science Section).
Her research is focused on the study of myocardial remodelling in chronic heart failure, specially fibrosis, with a double aim: Identifying clinically useful non-invasive circulating biomarkers for improved diagnosis, risk stratification and personalized management; delving into fibrosis mechanisms to identify novel therapeutic targets. She has contributed to over 175 scientific publications (H index of 68) and she has led over 20 competitive research projects including National (Spanish) and European Commission-funded projects.
